Investor Relations

Webcast

Register to Listen to Q4 2014 Financial Results Call

Register Now

AxoGen to Present at JMP Securities Life Sciences Conference

AxoGen to Attend Wedbush PacGrow Life Sciences 2015 Life Sciences Management Access Conference

Symbol

NASDAQ: AXGN

Price

Loading...

Change

Loading...

Shares Oustanding

24926014

MKT Cap

Loading...

Volume

Loading...

AxoGen is a leading medical technology company dedicated to peripheral nerve repair. AxoGen's portfolio of regenerative medicine products is available in the United States, Canada and several other countries, and includes Avance® Nerve Graft, the only off-the-shelf commercially available processed nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site, AxoGuard® Nerve Connector, a porcine submucosa extracellular matrix ("ECM") coaptation aid for tensionless repair of severed nerves, and AxoGuard® Nerve Protector, a porcine submucosa ECM product used to wrap and protect injured peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments.